Vol. 41 No. 1 (2019): Experimental Oncology

Minireview

  • Quinazoline compounds for antitumor treatment

    G.I. Solyanik
    3-6
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12414

Original contributions

  • Evaluation of dose calculation algorithms using different density materials for in-field and out-of-field conditions

    S. Alghamdi, A. Tajaldeen
    46-52
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12529
  • Expression profiling of plac1 in murine cancer cell lines

    J. Mahmoudian, R. Ghods, M. Nazari, M. Jeddi-Tehrani, M.H. Ghahremani, S.N. Ostad, A.H. Zarnani
    7-13
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12743
  • Integral characteristic of the immune system state predicts breast cancer outcome

    M. Stakheyeva, D. Eidenzon, E. Slonimskaya, M. Patysheva, I. Bogdashin, E. Kolegova, E. Grigoriev, E. Choinzonov, N. Cherdyntseva
    32-38
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12593
  • The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma

    Yu.V. Lozovska, I.M. Andrusishina, N.Yu. Lukianova, A.P. Burlaka, L.A. Naleskina, I.N. Todor, V.F. Chekhun
    20-25
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12471
  • Analysis of LPL gene expression in patients with chronic lymphocytic leukemia

    N. Bilous, I. Abramenko, A. Chumak, I. Dyagil, Z. Martina
    39-45
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12391
  • Copy number alterations and copy-neutral loss of heterozygosity in Ukrainian patients with primary myelofibrosis

    L. Poluben, Ch.R. Bryke, Y. Hsu, O. Shumeiko, L. Neumerzhitska, B. Klimuk, L. Rybchenko, S. Klymenko, S.P. Balk, P.G. Fraenkel
    53-56
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12540
  • Radiation research to determine local tumor invasion in patients with cervical cancer

    O.A. Bakai, T.S. Golovko, A.V. Ganich, O.N. Gavriluk, A.V. Ashykhmin
    57-60
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12596
  • Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma

    D.L. Kolesnik, O.N. Pyaskovskaya, Yu.R. Yakshibaeva, G.I. Solyanik
    14-19
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12432
  • DNA oxidation in patients with metastastic colorectal cancer: clinical significance of 8-hydroxy-deoxyguanosine as an independent prognostic factor

    A.A. Burlaka, A.V. Vovk, A.P. Burlaka, O.O. Kolesnik
    26-31
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12554

Short communications

  • Assessment of trace elements in serum of acute lymphoblastic and myeloid leukemia patients

    S. Valadbeigi, S. Javadian, M. Ebrahimi-Rad, S. Khatami, R. Saghiri
    69-71
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12730

Case report

  • Cutaneous leiomyosarcoma: a clinical, dermoscopic, pathologic case study

    V. De Giorgi, F. Scarfì, F. Silvestri, P. Maida, A. Gori, L. Trane, D. Massi
    80-81
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12816
  • Parathyroid carcinoma: a case report

    R. Tkachenko, L. Zakhartseva, A. Golovko, O. Kuryk, G. Lazarenko
    72-75
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12775
  • A case of synchronous bilateral calyx urothelial carcinoma: combined treatment approach

    S. Semko, M. Pikul, O. Voylenko, O. Stakhovskyi, O. Kononenko, Yu. Vitruk, E. Stakhovsky
    76-79
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12791

Letter to editor

Hypothesis

  • Aggregated proteins in malignant and benign neoplasms

    D.I. Zabolotnyi, A.A. Belousova, D.D. Zabolotna, T.D. Savchenko, N.M. Voroshylova, M.D. Timchenko, I.R. Tsvirinko, S.V. Verevka
    61-68
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12629